Vantage Consulting Group’s Abbott ABT Stock Holding History

Vantage Consulting Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,536	Closed	-$168K	–	110
2020 Q4	$168K	Buy	+1,536	New	+$167K	0.01%	69

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vantage Consulting Group's ABT Position: Q1 2021 in Review

Vantage Consulting Group sold out of Abbott (ABT) in Q1 2021, closing a stake of 1,536 shares — an estimated $168K sold.

Vantage Consulting Group first reported a position in ABT in Q4 2020 and held it in 1 quarter. The position peaked at $168K in Q4 2020. 2,525 funds tracked by Wall St. Rank hold ABT as of Q1 2021.

Vantage Consulting Group reported no remaining Abbott position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 1,536 Abbott shares in Q1 2021, an estimated $168K.
Vantage Consulting Group first reported a position in Abbott in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Abbott position peaked at $168K in Q4 2020.
2,525 funds tracked by Wall St. Rank held Abbott as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.